Gideon Blumenthal (MD)
Supervisory Associate Director (Acting)
Office of Oncologic Diseases (OOD): Immediate Office
Dr Gideon Blumenthal is a Medical Oncologist and Hematologist who is currently Vice President, Global Regulatory Affairs in Oncology, Merck. Prior to joining Merck in 2020, Dr Blumenthal spent over a decade at the US Food and Drug Administration Oncology office, taking on increasing leadership responsibilities during his time at the Agency. He initially served as a medical reviewer, then clinical team leader, followed by Acting Deputy Director in the Office of Hematology Oncology Products and Associate Director for Precision Oncology, and most recently served as the Deputy Center Director of the Oncology Center for Excellence. Dr Blumenthal trained in Internal Medicine at the University of Maryland, followed by a Hematology and Medical Oncology fellowship at the National Cancer Institute. He also was an attending physician in the NCI thoracic oncology clinic. He received numerous awards, including the 2018 American Society for Clinical Oncology Public Service Award. He has co-authored over 100 articles in the Oncology and Drug Development peer reviewed literature and authored numerous book chapters.